Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Expression pattern of the cannabinoid receptor genes in the frontal cortex of mood disorder patients and mice selectively bred for high and low fear.

Choi K, Le T, McGuire J, Xing G, Zhang L, Li H, Parker CC, Johnson LR, Ursano RJ.

J Psychiatr Res. 2012 Jul;46(7):882-9. doi: 10.1016/j.jpsychires.2012.03.021. Epub 2012 Apr 23.

PMID:
22534181
2.

CB1 cannabinoid receptors modulate kinase and phosphatase activity during extinction of conditioned fear in mice.

Cannich A, Wotjak CT, Kamprath K, Hermann H, Lutz B, Marsicano G.

Learn Mem. 2004 Sep-Oct;11(5):625-32.

3.

CB1 and CB2 cannabinoid receptor expression during development and in epileptogenic developmental pathologies.

Zurolo E, Iyer AM, Spliet WG, Van Rijen PC, Troost D, Gorter JA, Aronica E.

Neuroscience. 2010 Sep 29;170(1):28-41. doi: 10.1016/j.neuroscience.2010.07.004. Epub 2010 Jul 13.

PMID:
20621164
4.

Immunohistochemical localization of CB1 cannabinoid receptors in frontal cortex and related limbic areas in obese Zucker rats: effects of chronic fluoxetine treatment.

Zarate J, Churruca I, Echevarría E, Casis L, López de Jesús M, Saenz del Burgo L, Sallés J.

Brain Res. 2008 Oct 21;1236:57-72. doi: 10.1016/j.brainres.2008.07.100. Epub 2008 Aug 3.

PMID:
18722357
5.

Expression profiles of mitochondrial genes in the frontal cortex and the caudate nucleus of developing humans and mice selectively bred for high and low fear.

Choi KH, Le T, McGuire J, Coyner J, Higgs BW, Diglisic S, Johnson LR, Benedek DM, Ursano RJ.

PLoS One. 2012;7(11):e49183. doi: 10.1371/journal.pone.0049183. Epub 2012 Nov 13.

6.

Cannabinoid receptors in conjunctival epithelium: identification and functional properties.

Iribarne M, Torbidoni V, Julián K, Prestifilippo JP, Sinha D, Rettori V, Berra A, Suburo AM.

Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4535-44. doi: 10.1167/iovs.07-1319. Epub 2008 Jun 19.

PMID:
18566465
7.

Dysregulation of cannabinoid CB1 receptor and associated signaling networks in brains of cocaine addicts and cocaine-treated rodents.

Álvaro-Bartolomé M, García-Sevilla JA.

Neuroscience. 2013 Sep 5;247:294-308. doi: 10.1016/j.neuroscience.2013.05.035. Epub 2013 May 29.

PMID:
23727505
8.

CB2 Cannabinoid Receptor Knockout in Mice Impairs Contextual Long-Term Memory and Enhances Spatial Working Memory.

Li Y, Kim J.

Neural Plast. 2016;2016:9817089. doi: 10.1155/2016/9817089. Epub 2015 Dec 27.

9.

Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system.

Schatz AR, Lee M, Condie RB, Pulaski JT, Kaminski NE.

Toxicol Appl Pharmacol. 1997 Feb;142(2):278-87.

PMID:
9070350
10.

Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain.

Onaivi ES, Ishiguro H, Gong JP, Patel S, Perchuk A, Meozzi PA, Myers L, Mora Z, Tagliaferro P, Gardner E, Brusco A, Akinshola BE, Liu QR, Hope B, Iwasaki S, Arinami T, Teasenfitz L, Uhl GR.

Ann N Y Acad Sci. 2006 Aug;1074:514-36. Review.

PMID:
17105950
11.

Antinociceptive effects of the non-selective cannabinoid receptor agonist CP 55,940 are absent in CB1(-/-) and not CB2(-/-) mice in models of acute and persistent pain.

Sain NM, Liang A, Kane SA, Urban MO.

Neuropharmacology. 2009 Sep;57(3):235-41. doi: 10.1016/j.neuropharm.2009.06.004. Epub 2009 Jun 16.

PMID:
19538975
12.
13.

Loss of mRNA levels, binding and activation of GTP-binding proteins for cannabinoid CB1 receptors in the basal ganglia of a transgenic model of Huntington's disease.

Lastres-Becker I, Berrendero F, Lucas JJ, Martín-Aparicio E, Yamamoto A, Ramos JA, Fernández-Ruiz JJ.

Brain Res. 2002 Mar 8;929(2):236-42.

PMID:
11864629
14.

Mice lacking cannabinoid CB1-, CB2-receptors or both receptors show increased susceptibility to trinitrobenzene sulfonic acid (TNBS)-induced colitis.

Engel MA, Kellermann CA, Burnat G, Hahn EG, Rau T, Konturek PC.

J Physiol Pharmacol. 2010 Feb;61(1):89-97.

15.

Overexpression of cannabinoid CB2 receptor in the brain induces hyperglycaemia and a lean phenotype in adult mice.

Romero-Zerbo SY, Garcia-Gutierrez MS, Suárez J, Rivera P, Ruz-Maldonado I, Vida M, Rodriguez de Fonseca F, Manzanares J, Bermúdez-Silva FJ.

J Neuroendocrinol. 2012 Aug;24(8):1106-19. doi: 10.1111/j.1365-2826.2012.02325.x.

PMID:
22487302
16.

Opposite regulation of cannabinoid CB1 and CB2 receptors in the prefrontal cortex of rats treated with cocaine during adolescence.

García-Cabrerizo R, García-Fuster MJ.

Neurosci Lett. 2016 Feb 26;615:60-5. doi: 10.1016/j.neulet.2016.01.018. Epub 2016 Jan 18.

PMID:
26797579
17.

Expression and function of cannabinoid receptors CB1 and CB2 and their cognate cannabinoid ligands in murine embryonic stem cells.

Jiang S, Fu Y, Williams J, Wood J, Pandarinathan L, Avraham S, Makriyannis A, Avraham S, Avraham HK.

PLoS One. 2007 Jul 25;2(7):e641.

18.

Methods to study the behavioral effects and expression of CB2 cannabinoid receptor and its gene transcripts in the chronic mild stress model of depression.

Onaivi ES, Ishiguro H, Sejal P, Meozzi PA, Myers L, Tagliaferro P, Hope B, Leonard CM, Uhl GR, Brusco A, Gardner E.

Methods Mol Med. 2006;123:291-8.

PMID:
16506415
19.

Shared changes in gene expression in frontal cortex of four genetically modified mouse models of depression.

Hoyle D, Juhasz G, Aso E, Chase D, del Rio J, Fabre V, Hamon M, Lanfumey L, Lesch KP, Maldonado R, Serra MA, Sharp T, Tordera R, Toro C, Deakin JF.

Eur Neuropsychopharmacol. 2011 Jan;21(1):3-10. doi: 10.1016/j.euroneuro.2010.09.011. Epub 2010 Oct 28.

PMID:
21030216
20.

CB1 receptor-deficient mice as a model for depression.

Valverde O, Torrens M.

Neuroscience. 2012 Mar 1;204:193-206. doi: 10.1016/j.neuroscience.2011.09.031. Epub 2011 Sep 19. Review.

PMID:
21964469

Supplemental Content

Support Center